These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7243679)

  • 1. Central action of Craviten (M-71).
    Maj J; Sowińska H; Baran L; Mogilnicka E; Przewłocka B
    Pol J Pharmacol Pharm; 1980; 32(6):823-32. PubMed ID: 7243679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of Craviten (M-71).
    Maj J; Kulig D; Myśliwiec D; Bugielska Z; Tomsa E; Zaczyńska-Kostrakiewicz M
    Pol J Pharmacol Pharm; 1980; 32(6):855-75. PubMed ID: 7243682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of teratogenic and embryotoxic properties of (2S, 2'S) N,N'-dimethyl-N,N'-bis [1-(3', 4', 5'-trimethoxybenzoyloxy)-butyl-2] ethylenediamine dihydrochloride (M-71).
    Dłuzniewski A; Gastoł-Lewińska L; Buczyńska B; Gródecka A; Kwiatek H
    Pol J Pharmacol Pharm; 1980; 32(6):893-908. PubMed ID: 7243686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a new antiarrhythmic drug: Craviten (M-71) on the ATP level in heart muscle slices in vitro.
    Gumińska M; Kedryna T; Marchut E; Eckstein M
    Pol J Pharmacol Pharm; 1980; 32(6):877-82. PubMed ID: 7243683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Craviten, a new antiarrhythmic drug, its 2R, 2'R isomer, quinidine and procaine amide on human platelet aggregation.
    Kedryna T; Gumińska M; Eckstein M
    Pol J Pharmacol Pharm; 1980; 32(6):883-8. PubMed ID: 7243684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of a new antiarrhythmic drug, Craviten (M-71) on the circulatory system in cats.
    Banaszkiewicz W; Chodera A
    Pol J Pharmacol Pharm; 1980; 32(6):841-8. PubMed ID: 7243681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacologic properties of pyridoyl derivatives of 3-methylaminoindole 2-methyltryptamine and isotryptamine.
    Misztal S; Wiertek J; Rogóz Z
    Arch Immunol Ther Exp (Warsz); 1976; 24(6):851-62. PubMed ID: 1015991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological study of new ethylenediamine derivatives with antiarrhythmic activity].
    Boni P; Bacciarelli C
    Farmaco Sci; 1974 Dec; 29(12):923-35. PubMed ID: 4442581
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.
    Kleinrok Z; Jagiełło-Wójtowicz E; Matuszek B; Chodkowska A
    Pol J Pharmacol Pharm; 1992; 44(3):227-39. PubMed ID: 1470561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro study of (2S, 2'S) N,N'-dimethyl-N, N'-bis [1(3', 4', 5'-trimethoxybenzoyloxy) butyl-2] ethylenediamine salts and their bioavailability.
    Krówczyński L; Kluczykowska B; Stozek T; Wajdowicz A; Bartkowicz S
    Pol J Pharmacol Pharm; 1980; 32(6):909-15. PubMed ID: 7243687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of buthobendin on glycolysis in rabbit myocardial slices in vitro.
    Marchut E; Gumińska M; Kedryna T
    Pol J Pharmacol Pharm; 1988; 40(2):167-72. PubMed ID: 3237566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological properties and clinical application of propolis. X. Preliminary pharmacological evaluation of ethanol extract of propolis (EEP).
    Kleinrok Z; Borzecki Z; Scheller S; Matuga W
    Arzneimittelforschung; 1978; 28(2):291-2. PubMed ID: 580395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A neuropharmacological study of isoteolin (IST)].
    Markov M; Zheliazkov D
    Eksp Med Morfol; 1990; 29(3):33-8. PubMed ID: 2276375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of some amides of substituted ethylenediamines on central nervous system.
    Sethi OP; Ismail AM; Bhavsar GC; Trivedi BM; Gulati OD
    Indian J Physiol Pharmacol; 1987; 31(2):125-9. PubMed ID: 3666881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N,N'-di-n-butyl-N,N'-dicarboxypiperidine-ethylenediamine as a new potent respiratory stimulant.
    Kasé Y; Nakanishi A; Kawasaki A; Miyata T; Katsukawa K; Nakanishi M; Tsumagari T
    Arch Int Pharmacodyn Ther; 1966 Sep; 163(1):133-8. PubMed ID: 4381957
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of a new antiarrhythmic drug, Craviten (M-71) on coronary flow.
    Banaszkiewicz W; Chodera A
    Pol J Pharmacol Pharm; 1980; 32(6):849-53. PubMed ID: 6787574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The search for new antiarrhythmics in the group of chirally 1,2-aminoalcohols. I. 3',4',5'-trimethoxybenzoic acid esters of optically active N,N'-dimethyl-N,N'-bis-(1-hydroxybutyl-2) ethylenediamines.
    Eckstein M; Herdegen E
    Pol J Pharmacol Pharm; 1980; 32(6):817-21. PubMed ID: 7243678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of the pharmacological effect of oxyphenamate].
    Gorshkova VK; Mikhaĭlova TV; Gilev AP
    Farmakol Toksikol; 1970; 33(3):264-7. PubMed ID: 5465696
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
    Terhaag B; Förster W
    Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.